Search - tctmd.com

Displaying 21 - 40 of 52

Sort: Relevancy | Date

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Daily News

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Yael L. Maxwell

September 17, 2018

News Conference News SCAI 2018

3-D Printing May Help TAVR Operators Avoid Paravalvular Leak

L.A. McKeown

April 26, 2018

News Conference News ACC 2018

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

Shelley Wood

March 10, 2018

News Daily News

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Shelley Wood

January 05, 2018

News Daily News

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Shelley Wood

December 19, 2017

News Industry News

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

August 01, 2017

News Industry News

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

May 15, 2017

News Opinion Conversations in Cardiology

Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough?

February 27, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Daily News

Transcatheter Valve-in-Ring for Failed Tricuspid Repair: New Hope for Patients With Few Options

Caitlin E. Cox

January 05, 2017

News Industry News

Boston Scientific Receives CE Mark For LOTUS Edge™ Valve System

September 19, 2016

News Industry News

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

May 20, 2015

News Industry News

Medtronic CoreValve® Evolut(TM) R System Yields Exceptional Outcomes in First Clinical Study

March 16, 2015

News Industry News

Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years

March 15, 2015

Advertisement

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

TCT 2019 Day Two: Transcatheter Valves, New and Old

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

3-D Printing May Help TAVR Operators Avoid Paravalvular Leak

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough?

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Transcatheter Valve-in-Ring for Failed Tricuspid Repair: New Hope for Patients With Few Options

Boston Scientific Receives CE Mark For LOTUS Edge™ Valve System

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

Medtronic CoreValve® Evolut(TM) R System Yields Exceptional Outcomes in First Clinical Study

Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content